BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9373812)

  • 1. Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.
    Rudant E; Bezie Y; Bonhomme-Faivre L; Manuel N; Rucay P; Fredj G; Bismuth H
    J Clin Pharm Ther; 1997 Apr; 22(2):135-40. PubMed ID: 9373812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus.
    Dietemann J; Berthoux P; Gay-Montchamp JP; Batie M; Berthoux F
    Nephrol Dial Transplant; 2001 Nov; 16(11):2246-9. PubMed ID: 11682676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in monitoring tacrolimus (FK 506).
    Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
    Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
    Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
    Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A; Hermida J; Tutor JC
    Ups J Med Sci; 2008; 113(1):103-10. PubMed ID: 18521804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents.
    MacFarlane G; Scheller D; Ersfeld D; Jensen T; Jevans A; Wong PY; Kobayashi M
    Ther Drug Monit; 1996 Dec; 18(6):698-705. PubMed ID: 8946668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay.
    Tomita T; Homma M; Hasegawa Y; Kojima H; Ohkohchi N; Hori T; Kaneko M; Nakano Y; Tobe T; Kohda Y
    Biol Pharm Bull; 2008 Jun; 31(6):1250-3. PubMed ID: 18520063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hematocrit value on microparticle enzyme immunoassay of tacrolimus concentration in therapeutic drug monitoring.
    Tomita T; Homma M; Yuzawa K; Ohkohchi N; Hori T; Kaneko M; Hasegawa Y; Kojima H; Nagasawa T; Kohda Y
    Ther Drug Monit; 2005 Feb; 27(1):94-7. PubMed ID: 15665753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.
    Cogill JL; Taylor PJ; Westley IS; Morris RG; Lynch SV; Johnson AG
    Clin Chem; 1998 Sep; 44(9):1942-6. PubMed ID: 9732981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation.
    Tolou-Ghamari Z; Wendon J; Tredger JM
    Clin Chem Lab Med; 2000 Nov; 38(11):1209-11. PubMed ID: 11156362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
    Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
    Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.